v3.25.4
Income Taxes
6 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
INCOME TAXES

NOTE 6. INCOME TAXES

 

United States

 

Longduoduo is subject to the U.S. corporation tax rate of 21%.

 

British Virgin Islands

 

The Company’s subsidiary, LDD, is incorporated in the BVI and is not subject to tax on income or capital gain. In addition, payments of dividends by LDD to its shareholders are not subject to withholding tax in the BVI.

 

Hong Kong

 

Longduoduo HK and LDDJK are incorporated in Hong Kong and are subject to Hong Kong profits tax. Each of them is subject to Hong Kong taxation on its activities conducted in Hong Kong and income arising in or derived from Hong Kong. From the year of assessment, 2019/2020, onwards, Hong Kong profits tax rates are 8.25% on assessable profits up to HK$2,000,000, and 16.5% on any part of assessable profits over HK$2,000,000. The Company did not have any income subject to the Hong Kong profits tax.

 

China

 

Julong and its subsidiaries are subject to a 25% standard enterprise income tax in the PRC. If the taxable income in the calendar year does not exceed RMB 3 million, only 25% of the taxable income will be included in the tax base, which is then subject to a preferential tax rate of 20%. The Company accrued $4,424 and $106,576 of PRC income tax for the six months ended December 31, 2025 and 2024. Additionally, for the six months ended December 31, 2025, Longduoduo HK incurred $62,690 in income tax to the Mainland China tax authority in connection with the transfer of its subsidiary Longduoduo Health Technology to Julong.

 

A summary of income (loss) before income taxes for domestic and foreign locations for the three and six months ended December 31, 2025 and 2024 is as follows:

 

   For the Three Months Ended
December 31,
 
   2025   2024 
United States  $(36,426)  $(28,728)
Foreign   (237,799)   636,723 
(Loss) income before income taxes  $(274,225)  $607,995 

 

   For the Six Months Ended
December 31,
 
   2025   2024 
United States  $(133,412)  $(138,500)
Foreign   (184,901)   687,171 
(Loss) income before income taxes  $(318,313)  $548,671 

The difference between the U.S. federal statutory income tax rate and the Company’s effective tax rate was as follows:

 

   For the Six Months Ended
December 31,
 
   2025   2024 
Income tax (benefit) at USA statutory rate   21%   21%
U.S. valuation allowance   (21)%   (21)%
Income tax (benefit) at USA effective rate   0%   0%

 

The difference between the PRC statutory income tax rate and the PRC effective tax rate was as follows:

 

   For the Six Months Ended
December 31,
 
   2025   2024 
Income tax (benefit) at PRC statutory rate   25%   25%
Utilization of net operating loss carry forward   0%   (7)%
Tax preference   (6)%   (2)%
PRC valuation allowance   (21)%   -%
Income tax (benefit) at PRC effective rate   (2)%   16%

 

The Company did not recognize deferred tax assets since it is not more likely than not that it will realize such deferred taxes. The deferred tax would apply to Longduoduo in the U.S. and Julong and subsidiaries in China.

 

As of December 31, 2025, Julong and its subsidiaries had total net operating loss carry forwards of approximately $639,269 in the PRC that expire through 2030. Due to the uncertainty of utilizing these carry forwards, the Company provided a 100% allowance on all deferred tax assets of approximately $159,817 and $103,712 related to its operations in the PRC as of December 31, 2025 and June 30, 2025, respectively. The PRC valuation allowance has increased by $56,105 and $0 for the six months ended December 31, 2025 and 2024, respectively.

 

The Company incurred losses from its United States operations during the six months ended December 31, 2025 of approximately $133,412. The Company’s United States operations consist solely of ownership of its foreign subsidiaries, and the losses arise from administration expenses. Accordingly, management provided a 100% valuation allowance of approximately $287,571 and $259,555 against the deferred tax assets related to the Company’s United States operations as of December 31, 2025 and June 30, 2025, respectively, because the deferred tax benefits of the net operating loss carry forwards in the United States are not likely to be utilized. The US valuation allowance has increased by approximately $28,016 and $29,085 for the six months ended December 31, 2025 and 2024, respectively.

The Company is subject to examination by the Internal Revenue Service (IRS) in the United States as well as by the taxing authorities in China, where the Company has significant business operations. The table below presents the earliest tax year that remains subject to examination by major jurisdiction. 

 

    Earliest tax year that
remains subject to examination
U.S. Federal   June 30, 2021
China   June 30, 2020